The impact of COVID-19 on the optimal management of osteoporosis

Sung Hye Kong, Bo Kwon Hwang, Byung Ho Yoon

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Osteoporosis does not take a break while Coronavirus disease 2019 (COVID-19) stunned and overtook everyone’s lives. Medical resources were immediately shifted, self-isolation and telemedicine were expanded, ambulatory care services such as bone densitometry and osteoporosis-centered clinics came to a near halt. Progress with fracture prevention has been challenged because osteoporotic fracture with low energy injury is more prevalent even though restriction of people’s movement. Thus we must re-engage with chronic bone health concerns and fracture prevention. This review discusses challenges in management of osteoporosis during the COVID-19 pandemic and reinforces the need to implementing recommendations concerning the importance of bone fragility care with at least those patients who are already treated with antiosteoporotic drugs maintaining their adherence to treatments.

Original languageEnglish
Pages (from-to)115-122
Number of pages8
JournalJournal of Bone Metabolism
Volume28
Issue number2
DOIs
StatePublished - May 2021

Keywords

  • COVID-19
  • Epidemics
  • Osteoporosis
  • Osteoporotic fractures

Fingerprint

Dive into the research topics of 'The impact of COVID-19 on the optimal management of osteoporosis'. Together they form a unique fingerprint.

Cite this